Stayble Therapeutics Company
%20.jpg)
Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain triggered by degenerative changes in the disc. Stayble’s treatment has the potential to offer a solution that may alleviate or abolish the pain without the need for surgery Behind Stayble Therapeutics stands an experienced, multidisciplinary team including a world-renowned back-pain researcher, experienced bio-entrepreneurs and former big pharma senior management. Their vision is that this treatment concept will reach out to millions of patients who are disabled by chronic back pain. We believe this drug has the potential to drastically reduce the suffering from a widespread, incapacitating condition.
%20.jpg)
Founded Date:
2012-01-01
Total Funding:
$6M
Investor Type:
For Profit
Employee Number:
1-10
Technology:
Others
Last Funding Type:
Venture - Series Unknown
Investors Number:
1
Industry:
Biotechnology, Health Care, Science and Engineering
Headquarters:
Göteborg, Vastra Gotaland, Sweden
Estimated Revenue:
$1M to $10M